Publications by authors named "Frederic Bornancin"

51Publications

Editorial: CARMA Proteins: Playing a Hand of Four CARDs.

Front Immunol 2019 29;10:1217. Epub 2019 May 29.

Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.

View Article and Find Full Text PDF
June 2020

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity.

J Vis Exp 2019 01 7(143). Epub 2019 Jan 7.

Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research;

View Article and Find Full Text PDF
January 2019

MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.

Biochem Biophys Res Commun 2018 11 15;506(1):48-52. Epub 2018 Oct 15.

Novartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland. Electronic address:

View Article and Find Full Text PDF
November 2018

Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.

Cell Signal 2018 Oct 18;50:1-8. Epub 2018 Jun 18.

Department of Biomedical Science and Shock/Trauma Research Center, School of Medicine, University of Missouri-Kansas City, 2411 Holmes Street, Kansas City, MO 64108, USA. Electronic address:

View Article and Find Full Text PDF
October 2018

Selective MALT1 paracaspase inhibition does not block TNF-α production downstream of TLR4 in myeloid cells.

Immunol Lett 2017 12 24;192:48-51. Epub 2017 Oct 24.

Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address:

View Article and Find Full Text PDF
December 2017

Ways and waves of MALT1 paracaspase activation.

Cell Mol Immunol 2018 01 7;15(1):8-11. Epub 2017 Aug 7.

Novartis Institutes for BioMedical Research, Novartis Campus, Basel CH-4002, Switzerland.

View Article and Find Full Text PDF
January 2018

Ceramide kinase: the first decade.

Cell Signal 2011 Jun 25;23(6):999-1008. Epub 2010 Nov 25.

Novartis Institutes for BioMedical Research, CH-4056 Basle, Switzerland.

View Article and Find Full Text PDF
June 2011

Transcriptional repression of ceramide kinase in LPS-challenged macrophages.

Biochem Biophys Res Commun 2010 Oct 16;401(1):164-7. Epub 2010 Sep 16.

Novartis Institutes for BioMedical Research, Brunnerstrasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
October 2010

Cleavage by MALT1 induces cytosolic release of A20.

Biochem Biophys Res Commun 2010 Oct 20;400(4):543-7. Epub 2010 Sep 20.

Novartis Institutes for BioMedical Research, Forum 1, Novartis Campus, CH-4056 Basle, Switzerland.

View Article and Find Full Text PDF
October 2010

Modulation of ceramide metabolism in mouse primary macrophages.

Biochem Biophys Res Commun 2010 Aug 15;399(2):150-4. Epub 2010 Jul 15.

Novartis Institutes for BioMedical Research, Brunnerstrasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
August 2010

Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1-/- mice.

Lipids Health Dis 2010 Jan 6;9. Epub 2010 Jan 6.

Novartis Institutes for BioMedical Research, Brunnerstrasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
January 2010

Ceramide kinase deficiency impairs microendothelial cell angiogenesis in vitro.

Microvasc Res 2009 May 6;77(3):389-93. Epub 2009 Feb 6.

Novartis Institutes for BioMedical Research, Brunnerstrasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
May 2009

A secondary assay for ceramide kinase inhibitors based on cell growth inhibition by short-chain ceramides.

Anal Biochem 2009 Jan 14;384(1):166-9. Epub 2008 Sep 14.

Novartis Institutes for BioMedical Research, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
January 2009

A conserved cysteine motif essential for ceramide kinase function.

Biochimie 2008 Oct 10;90(10):1560-5. Epub 2008 Jul 10.

Novartis Institutes for BioMedical Research, Vienna, Vienna, Austria.

View Article and Find Full Text PDF
October 2008

Wild-type levels of ceramide and ceramide-1-phosphate in the retina of ceramide kinase-like-deficient mice.

Biochem Biophys Res Commun 2008 Aug 12;373(1):159-63. Epub 2008 Jun 12.

Novartis Institutes for BioMedical Research, Brunnerstrasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
August 2008

Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice.

Immunol Lett 2007 Mar 30;109(1):56-63. Epub 2007 Jan 30.

Novartis Institutes for BioMedical Research, Vienna, Brunnerstrasse 59, A-1235 Wien, Austria.

View Article and Find Full Text PDF
March 2007

Enhanced ceramide-induced apoptosis in ceramide kinase overexpressing cells.

Biochem Biophys Res Commun 2007 Mar 8;354(1):309-14. Epub 2007 Jan 8.

Novartis Institutes for BioMedical Research, Brunnerstrasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
March 2007

Characterization of a ceramide kinase-like protein.

Biochim Biophys Acta 2005 Feb;1687(1-3):31-43

Novartis Institutes for BioMedical Research, Brunnerstrasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
February 2005

The role of sphingosine and ceramide kinases in inflammatory responses.

Immunol Lett 2005 Jan;96(2):175-85

Novartis Institute for BioMedical Research Vienna, Brunner Strasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
January 2005

Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases.

J Biol Chem 2003 Nov 16;278(48):47408-15. Epub 2003 Sep 16.

Novartis Research Institute, Brunnerstrasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
November 2003

Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors.

Cell Signal 2002 Oct;14(10):829-37

Département de Pharmacologie Moléculaire et Cellulaire, Institut de Recherches Servier, 125, Chemin de Ronde, 78290 Croissy-sur-Seine, France.

View Article and Find Full Text PDF
October 2002